Healthcare provider profile · identity verified

John Culmine, MD

Internal Medicine · BRONX, NY · NPI 1639254832

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	743	226
Atorvastatin Calcium	Atorvastatin Calcium	665	207
Metformin Hcl	Metformin Hcl	432	119
Losartan Potassium	Losartan Potassium	423	124
Metoprolol Succinate	Metoprolol Succinate	337	105
Rosuvastatin Calcium	Rosuvastatin Calcium	334	102
Albuterol Sulfate Hfa	Albuterol Sulfate	321	107
Hydrochlorothiazide	Hydrochlorothiazide	245	74
Fluticasone Propionate	Fluticasone Propionate	222	68
Lisinopril	Lisinopril	209	67
Omeprazole	Omeprazole	206	67
Tamsulosin Hcl	Tamsulosin Hcl	198	56
Levothyroxine Sodium	Levothyroxine Sodium	185	57
Pioglitazone Hcl	Pioglitazone Hcl	167	43
Gabapentin	Gabapentin	163	60
Jardiance	Empagliflozin	161	43
Simvastatin	Simvastatin	143	49
Ozempic	Semaglutide	133	38
Montelukast Sodium	Montelukast Sodium	120	40
Eliquis	Apixaban	115	32
Felodipine Er	Felodipine	115	32
Famotidine	Famotidine	112	41
Sertraline Hcl	Sertraline Hcl	103	25
Pravastatin Sodium	Pravastatin Sodium	97	34
Pantoprazole Sodium	Pantoprazole Sodium	96	33
Naproxen	Naproxen	87	43
Nifedipine Er	Nifedipine	85	29
Trulicity	Dulaglutide	85	18
Prednisone	Prednisone	83	43
Furosemide	Furosemide	82	30
Alcohol Prep Pads	Alcohol Antiseptic Pads	78	24
Glimepiride	Glimepiride	77	24
Januvia	Sitagliptin Phosphate	76	18
Meclizine Hcl	Meclizine Hcl	74	26
Metformin Hcl Er	Metformin Hcl	71	25
Metoprolol Tartrate	Metoprolol Tartrate	71	21
Single Use Swab	Alcohol Antiseptic Pads	68	24
Duloxetine Hcl	Duloxetine Hcl	67	21
Clopidogrel	Clopidogrel Bisulfate	63	22
Finasteride	Finasteride	61	17
Mometasone Furoate	Mometasone Furoate	56	23
Meloxicam	Meloxicam	55	17
Ibuprofen	Ibuprofen	53	26
Ammonium Lactate	Ammonium Lactate	52	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	19
Atenolol	Atenolol	50	14
Alendronate Sodium	Alendronate Sodium	49	14
Azelastine Hcl	Azelastine Hcl	49	16
Diclofenac Sodium	Diclofenac Sodium	49	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	15
Farxiga	Dapagliflozin Propanediol	45	16
Synthroid	Levothyroxine Sodium	44	13
Mounjaro	Tirzepatide	43	11
Carvedilol	Carvedilol	42	12
Allopurinol	Allopurinol	40	suppressed
Potassium Chloride	Potassium Chloride	39	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	16
Escitalopram Oxalate	Escitalopram Oxalate	37	suppressed
Ketoconazole	Ketoconazole	37	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	suppressed
Valsartan	Valsartan	37	15
Candesartan Cilexetil	Candesartan Cilexetil	36	12
Celecoxib	Celecoxib	35	suppressed
Ezetimibe	Ezetimibe	35	13
Glipizide Er	Glipizide	35	12
Ventolin Hfa	Albuterol Sulfate	35	suppressed
Alprazolam	Alprazolam	34	11
Clonazepam	Clonazepam	34	suppressed
Hydralazine Hcl	Hydralazine Hcl	34	11
Mirtazapine	Mirtazapine	33	11
Terazosin Hcl	Terazosin Hcl	33	11
Amiodarone Hcl	Amiodarone Hcl	32	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	31	13
Tramadol Hcl	Tramadol Hcl	31	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	31	suppressed
Desloratadine	Desloratadine	30	suppressed
Levemir Flexpen	Insulin Detemir	30	12
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Diazepam	Diazepam	27	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Nystatin	Nystatin	27	13
Glipizide	Glipizide	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Azithromycin	Azithromycin	25	24
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	23	suppressed
Labetalol Hcl	Labetalol Hcl	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Loperamide	Loperamide Hcl	21	suppressed
Nebivolol Hcl	Nebivolol Hcl	21	suppressed
Tradjenta	Linagliptin	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Synjardy	Empagliflozin/Metformin Hcl	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Baclofen	Baclofen	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Alcohol Swab	Alcohol Antiseptic Pads	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Arnuity Ellipta	Fluticasone Furoate	15	suppressed
Cephalexin	Cephalexin	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Dulera	Mometasone/Formoterol	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Estradiol (Twice Weekly)	Estradiol	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Risperidone	Risperidone	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Fosinopril Sodium	Fosinopril Sodium	12	suppressed
Imipramine Hcl	Imipramine Hcl	12	suppressed
Restasis	Cyclosporine	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	11
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Methimazole	Methimazole	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Topiramate	Topiramate	11	suppressed
Torsemide	Torsemide	11	suppressed
Trazodone Hcl	Trazodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error